Clinical Trials Browser

Unknown × Breast Neoplasms × Neoadjuvant Therapy × Clear all

NCT05912062 2023-09-29

BiOnHER

Breast Neoplasms, Neoplasms

NCT05642104 2022-12-08

The Detection of Cell-in-cell Structure (CICs) in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy

Breast Neoplasms

NCT05479409 2022-07-29

Neoadjuvant Radiation in Locally Advanced Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT05441098 2022-07-01

Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology

Pathologic Complete Response, Breast Neoplasms

NCT02251353 2020-02-21

IMET

Breast Neoplasms, Neoplasm Metastasis

NCT04156841 2019-11-08

Sentinel Lymph Node Biopsy in Early Breast Cancer: a Real-world Multicenter Cross-sectional Study (CABS001 Study)

21,000 enrolled

Breast Neoplasms

NCT03520894 2019-10-22

ROCK

Phase NA Unknown

Breast Neoplasms

NCT01104571 2018-09-17

EPHOS-B

Phase 3 Unknown

Breast Neoplasms

NCT03592004 2018-07-19

Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer

Breast Neoplasms

NCT00491816 2017-01-19

Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer

Phase 2 Unknown

Breast Neoplasms, Neoplasms

NCT02934828 2016-10-18

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00671476 2014-01-10

Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery

Phase NA Unknown

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00036985 2013-12-19

Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00036998 2013-11-06

Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00533936 2013-08-26

Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00070278 2013-08-07

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00072020 2013-08-02

Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer

Phase 3 Unknown

Breast Neoplasms, Neoplasm Metastasis

NCT00830544 2012-07-13

Neoadjuvant

Phase 2 Unknown

Breast Neoplasms

NCT00398489 2010-11-09

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Phase 2 Unknown

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00994968 2010-10-29

Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00251329 2007-04-04

Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery

Phase 2 Unknown

Breast Neoplasms